ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Cipher Pharmaceuticals, Inc. ?
1
High Management Efficiency with a high ROE of 25.10%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 12.64
3
With a growth in Net Profit of 116.61%, the company declared Very Positive results in Jun 25
- The company has declared positive results in Jan 70 after 2 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at CAD 29.43 MM
- NET SALES(Q) Highest at CAD 18.52 MM
- INVENTORY TURNOVER RATIO(HY) Highest at 4.72%
4
With ROE of 11.37%, it has a fair valuation with a 2.70 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 12.42%, its profits have fallen by -44.5%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Cipher Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Cipher Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Cipher Pharmaceuticals, Inc.
-6.6%
1.57
50.96%
S&P/TSX 60
19.1%
1.54
14.62%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
17.30%
EBIT Growth (5y)
-11.25%
EBIT to Interest (avg)
12.64
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0.17
Sales to Capital Employed (avg)
0.27
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
37.30%
ROE (avg)
25.10%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
2.49
EV to EBIT
39.27
EV to EBITDA
19.73
EV to Capital Employed
2.32
EV to Sales
5.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.91%
ROE (Latest)
11.37%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD 29.43 MM
NET SALES(Q)
Highest at CAD 18.52 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 4.72%
DEBTORS TURNOVER RATIO(HY)
Highest at 6.22%
OPERATING PROFIT(Q)
Highest at CAD 9.41 MM
OPERATING PROFIT MARGIN(Q)
Highest at 50.8 %
PRE-TAX PROFIT(Q)
Highest at CAD 8.86 MM
NET PROFIT(Q)
Highest at CAD 8.16 MM
EPS(Q)
Highest at CAD 0.31
-6What is not working for the Company
INTEREST(9M)
At CAD 1.91 MM has Grown at inf%
RAW MATERIAL COST(Y)
Grown by 8% (YoY
Here's what is working for Cipher Pharmaceuticals, Inc.
Pre-Tax Profit
At CAD 8.86 MM has Grown at 1,262.52%
over average net sales of the previous four periods of CAD 0.65 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CAD MM)
Operating Cash Flow
Highest at CAD 29.43 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Net Sales
Highest at CAD 18.52 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (CAD MM)
Net Profit
At CAD 8.16 MM has Grown at 152.38%
over average net sales of the previous four periods of CAD 3.23 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CAD MM)
Net Sales
At CAD 18.52 MM has Grown at 34.24%
over average net sales of the previous four periods of CAD 13.79 MMMOJO Watch
Near term sales trend is positive
Net Sales (CAD MM)
Operating Profit
Highest at CAD 9.41 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CAD MM)
Operating Profit Margin
Highest at 50.8 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CAD 8.86 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CAD MM)
Net Profit
Highest at CAD 8.16 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
EPS
Highest at CAD 0.31
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CAD)
Inventory Turnover Ratio
Highest at 4.72%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 6.22%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Cipher Pharmaceuticals, Inc.
Interest
At CAD 1.91 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CAD MM)
Raw Material Cost
Grown by 8% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
